Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s41207-021-00263-6 http://scihub22266oqcxt.onion/10.1007/s41207-021-00263-6 34250222!8254859!34250222     free     free     free       EuroMediterr+J+Environ+Integr 2021 ; 6 (2): 61 Nephropedia Template TP {{tp|p=34250222|t=2021. Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2 |pdf=|usr=}}{{34250222}} gab.com Text Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2 JO: EuroMediterr J Environ Integr http://www.kidney.de/pget.php?&tw=1&pmid=34250222 #FOAvip The novel coronavirus disease 2019 (COVID-19) that emerged in China has spread to more than 212 countries to date. COVID-19 can cause serious acute respiratory syndrome (SARS). Therefore, research advances on the associated SARS-coronavirus-2 (CoV-2) may enable the scientific community to establish effective vaccines to prevent SARS-CoV-2 infections by increasing understanding of viral pathogenesis. Measles virus (MV) expressing SARS-CoV-2 spike protein (S) represents a promising class of biotherapeutic agents to combat this virus. The potential of such recombinant viruses has been well recognized for the treatment of many diseases. We summarize and review herein a potential therapeutic intervention strategy against COVID-19 infection based on MVSchw2-SARS-S and MVSchw2-SARS-Ssol with the aim of assessing the suitability of recombinant MV as a potential new candidate SARS vaccine. Such analysis of COVID-19 pathogenesis could also help establish appropriate therapeutic targets for the production of specific antiviral agents against this newly emerged pathogen. Twit Text FOAVip Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2 ????EuroMediterr J Environ Integr http://www.kidney.de/pget.php?&tw=1&pmid=34250222 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34250222 #FOAvip English Wikipedia <ref>{{Cite pmid|34250222}}</ref> Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2 #MMPMID34250222 Jbeli R; Jelassi A EuroMediterr J Environ Integr 2021[]; 6 (2): 61 PMID34250222show ga The novel coronavirus disease 2019 (COVID-19) that emerged in China has spread to more than 212 countries to date. COVID-19 can cause serious acute respiratory syndrome (SARS). Therefore, research advances on the associated SARS-coronavirus-2 (CoV-2) may enable the scientific community to establish effective vaccines to prevent SARS-CoV-2 infections by increasing understanding of viral pathogenesis. Measles virus (MV) expressing SARS-CoV-2 spike protein (S) represents a promising class of biotherapeutic agents to combat this virus. The potential of such recombinant viruses has been well recognized for the treatment of many diseases. We summarize and review herein a potential therapeutic intervention strategy against COVID-19 infection based on MVSchw2-SARS-S and MVSchw2-SARS-Ssol with the aim of assessing the suitability of recombinant MV as a potential new candidate SARS vaccine. Such analysis of COVID-19 pathogenesis could also help establish appropriate therapeutic targets for the production of specific antiviral agents against this newly emerged pathogen. ?Current vaccine technology with an emphasis on recombinant measles vir(epmc).pdf DeepDyve Pubget Overpricing